Our latest eBook highlights breakthroughs that are redefining cancer care. Explore quadruplet therapies for multiple myeloma, protein degradation strategies targeting pediatric tumors, the transformative role of AI in cytogenetics and non-invasive diagnostic tools such as a eNose. This eBook illustrates how innovative technologies and collaborative research are paving the way for a future where cancer treatment is more personalized and accessible.
Highlights include:
- [RESEARCH ARTICLE] Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small-cell lung cancer
- [INTERVIEW] Deciphering the T-cell receptor cancer-recognition code
- [EDITORIAL] Cancer cytogenetics in the era of artificial intelligence: shaping the future of chromosome analysis
- [RAPID COMMUNICATION] Diagnosis of chondrosarcoma in a noninvasive way using volatile organic compounds in exhaled breath: a pilot study
- [INTERVIEW] The more the better? Quadruplets in newly diagnosed multiple myeloma
